Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $3 from $5 and keeps a Hold rating on the shares. The firm believes the stock “remains in the proving grounds,” but adds it is encouraged by emerging better ad delivery performance and supply side inventory. The firm cites broader multiple compression in the space for its price target cut.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDLX: